Envista Stock (NYSE:NVST)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$15.14

52W Range

$14.22 - $23.00

50D Avg

$18.28

200D Avg

$18.68

Market Cap

$2.59B

Avg Vol (3M)

$3.04M

Beta

1.12

Div Yield

-

NVST Company Profile


Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Show More

Industry

Medical - Equipment & Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

12,300

IPO Date

Sep 18, 2019

Website

NVST Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24Dec 23Dec 22
Specialty Products and Technologies$1.62B$1.64B-
Equipment and Consumables$894.20M$924.10M-
Equipment Sales--$421.60M
Consumables--$2.15B

Fiscal year ends in Dec 24 | Currency in USD

NVST Financial Summary


Dec 24Dec 23Dec 22
Revenue-$2.57B$2.57B
Operating Income-$31.50M$319.20M
Net Income$-1.12B$-100.20M$243.10M
EBITDA-$171.10M$484.40M
Basic EPS$-6.49$-0.60$1.46
Diluted EPS$-6.45$-0.60$1.34

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Feb 05, 25 | 5:30 PM
Q3 24Oct 30, 24 | 5:00 PM
Q2 24Aug 07, 24 | 5:00 PM

Peer Comparison


TickerCompany
ATRAptarGroup, Inc.
RMDResMed Inc.
ICUIICU Medical, Inc.
HOLXHologic, Inc.
MMSIMerit Medical Systems, Inc.
AKYAAkoya Biosciences, Inc.
COOThe Cooper Companies, Inc.
ATRCAtriCure, Inc.
WSTWest Pharmaceutical Services, Inc.
TFXTeleflex Incorporated
HAEHaemonetics Corporation
ANGOAngioDynamics, Inc.
ALCAlcon Inc.